Dermatologic Disease clinical trials at UCLA

1 in progress, 0 open to eligible people

Showing trials for

  • Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis

    Sorry, in progress, not accepting new patients

    This is a Phase 2a, multicenter, randomized, double-blind, placebo-controlled study with an open-label extension to evaluate the efficacy and safety of camoteskimab in adults with moderate to severe AD.

    Los Angeles 5368361, California 5332921 and other locations

Our lead scientists for Dermatologic Disease research studies include .

Last updated: